Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$29.24
-2.4%
$32.68
$27.07
$40.28
$1.22B1.31384,454 shs369,156 shs
NovoCure Limited stock logo
NVCR
NovoCure
$11.59
-0.3%
$15.42
$10.87
$34.13
$1.30B0.612.24 million shs1.41 million shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$37.78
-5.3%
$34.55
$5.21
$46.58
$341.69M1.2950,795 shs26,879 shs
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$6.75
+3.8%
$5.93
$0.32
$22.42
$1.26BN/A95,481 shs70,430 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
-2.19%-5.93%-8.73%-16.76%-13.84%
NovoCure Limited stock logo
NVCR
NovoCure
-0.47%+0.70%-30.97%-35.22%-33.77%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-5.27%+10.08%+13.56%+16.93%+3,777,999,900.00%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
+3.85%+1.05%+26.64%-31.40%+674,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cadre Holdings, Inc. stock logo
CDRE
Cadre
1.5826 of 5 stars
1.01.02.50.01.13.31.9
NovoCure Limited stock logo
NVCR
NovoCure
3.9918 of 5 stars
3.32.00.04.51.93.30.0
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
2.5331 of 5 stars
3.50.00.00.03.22.50.0
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.00
Hold$31.507.71% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.57
Moderate Buy$28.79148.37% Upside
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
3.00
Buy$49.0029.70% Upside
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SNWV, SSII, NVCR, and CDRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underperform$38.00 ➝ $26.00
7/29/2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$49.00
7/25/2025
NovoCure Limited stock logo
NVCR
NovoCure
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$40.00 ➝ $14.50
7/8/2025
NovoCure Limited stock logo
NVCR
NovoCure
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
6/27/2025
NovoCure Limited stock logo
NVCR
NovoCure
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$34.00
6/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$45.00 ➝ $38.00
(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$567.56M2.10$1.38 per share21.14$8.18 per share3.58
NovoCure Limited stock logo
NVCR
NovoCure
$605.22M2.14N/AN/A$3.13 per share3.70
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$32.63M9.92N/AN/A($1.72) per share-21.97
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$20.65M63.28N/AN/A$0.22 per share30.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9431.1121.501.106.65%12.08%5.60%N/A
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/29/2025 (Estimated)
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$31.37M-$8.25N/AN/A-97.03%N/A-135.15%N/A
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
-$19.15MN/A0.00N/A-40.20%-40.41%-20.80%N/A

Latest SNWV, SSII, NVCR, and CDRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q2 2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$0.09$0.01+$0.10$0.01$10.14 million$10.16 million
8/5/2025Q2 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.25$0.30+$0.05$0.30$153.23 million$157.11 million
7/24/2025Q2 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.30%N/A40.43%2 Years
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/AN/AN/AN/AN/A

Latest SNWV, SSII, NVCR, and CDRE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.16%8/1/20258/1/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.90
3.59
2.56
NovoCure Limited stock logo
NVCR
NovoCure
0.28
1.45
1.39
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A
0.43
0.31
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A
2.59
1.66

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
31.50%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.90%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million27.86 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.80 million105.63 millionOptionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.57 million7.29 millionN/A
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
4193.59 millionN/AN/A

Recent News About These Companies

Ss Innovations (SSII) Q2 Revenue Up 122%
SS Innovations Reports Second Quarter 2025 Financial Results
SS Innovations: A Speculative Bet On Robotic Surgeries

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cadre stock logo

Cadre NYSE:CDRE

$29.24 -0.71 (-2.36%)
Closing price 08/14/2025 03:59 PM Eastern
Extended Trading
$29.22 -0.02 (-0.08%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$11.59 -0.03 (-0.26%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$11.78 +0.19 (+1.64%)
As of 05:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$37.78 -2.10 (-5.27%)
As of 08/14/2025 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

SS Innovations International stock logo

SS Innovations International NASDAQ:SSII

$6.75 +0.25 (+3.85%)
As of 08/14/2025 04:00 PM Eastern

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.